{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:04:50Z","timestamp":1779923090867,"version":"3.53.1"},"reference-count":20,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1111\/all.13076","type":"journal-article","created":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T04:22:45Z","timestamp":1478492565000},"page":"320-324","source":"Crossref","is-referenced-by-count":84,"title":["Treatment for hereditary angioedema with normal C1-INH and specific mutations in the<i>F12<\/i>gene (HAE-FXII)"],"prefix":"10.1111","volume":"72","author":[{"given":"K.","family":"Bork","sequence":"first","affiliation":[{"name":"Department of Dermatology; Johannes Gutenberg University; Mainz Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Wulff","sequence":"additional","affiliation":[{"name":"University Medicine; Ernst Moritz Arndt University; Greifswald Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Witzke","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Johannes Gutenberg University; Mainz Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hardt","sequence":"additional","affiliation":[{"name":"Department of Medical Psychology and Medical Sociology; Johannes Gutenberg University; Mainz Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"10.1111\/all.13076-BIB0001|all13076-cit-0001","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1-inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/all.13076-BIB0002|all13076-cit-0002","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.bbrc.2006.03.092","article-title":"Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor","volume":"343","author":"Dewald","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/all.13076-BIB0003|all13076-cit-0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clim.2011.07.002","article-title":"A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor","volume":"141","author":"Bork","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1111\/all.13076-BIB0004|all13076-cit-0004","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clim.2013.08.001","article-title":"Novel duplication in the F12 gene in a patient with recurrent angioedema","volume":"149","author":"Kiss","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1111\/all.13076-BIB0005|all13076-cit-0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jaci.2009.03.038","article-title":"Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy","volume":"124","author":"Bork","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13076-BIB0006|all13076-cit-0006","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1365-2133.2007.07778.x","article-title":"A case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene","volume":"156","author":"Bouillet","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/all.13076-BIB0007|all13076-cit-0007","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.anai.2012.05.022","article-title":"Clinical, biochemical, and genetic characterization of type III hereditary angioedema in 13 Northwest Spanish families","volume":"109","author":"Marcos","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/all.13076-BIB0008|all13076-cit-0008","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S1081-1206(10)60369-9","article-title":"Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks","volume":"103","author":"Bouillet","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/all.13076-BIB0009|all13076-cit-0009","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clim.2015.02.013","article-title":"Characterization of patients with angioedema without wheals: the importance of F12 gene screening","volume":"157","author":"Firinu","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1111\/all.13076-BIB0010|all13076-cit-0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaci.2007.07.002","article-title":"Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene","volume":"120","author":"Martin","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13076-BIB0011|all13076-cit-0011","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000376547","article-title":"Coagulation factor XII gene mutation in Brazilian families with hereditary angioedema with normal C1 inhibitor","volume":"166","author":"Moreno","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/all.13076-BIB0012|all13076-cit-0012","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/cei.12379","article-title":"Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients","volume":"178","author":"Wintenberger","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/all.13076-BIB0013|all13076-cit-0013","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/all.12648","article-title":"Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations","volume":"70","author":"Bork","year":"2015","journal-title":"Allergy"},{"key":"10.1111\/all.13076-BIB0014|all13076-cit-0014","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1111\/hae.12519","article-title":"Characterization of a partial exon 9\/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitor","volume":"20","author":"Bork","year":"2014","journal-title":"Haemophilia"},{"key":"10.1111\/all.13076-BIB0015|all13076-cit-0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2217\/imt.14.33","article-title":"Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema","volume":"6","author":"Bork","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1111\/all.13076-BIB0016|all13076-cit-0016","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/cea.12055","article-title":"Benefits of progestin contraception in non-allergic angioedema","volume":"43","author":"Saule","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/all.13076-BIB0017|all13076-cit-0017","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MBC.0b013e32832811f8","article-title":"Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys","volume":"20","author":"Bork","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/all.13076-BIB0018|all13076-cit-0018","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.jaci.2015.07.041","article-title":"Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels","volume":"137","author":"Joseph","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.13076-BIB0019|all13076-cit-0019","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/MBC.0b013e3282dded21","article-title":"Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity","volume":"18","author":"Agren","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/all.13076-BIB0020|all13076-cit-0020","first-page":"129","article-title":"Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin","volume":"120","author":"Kleniewski","year":"1992","journal-title":"J Lab Clin Med"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fall.13076","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fall.13076","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/all.13076\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:58:09Z","timestamp":1498359489000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/all.13076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"URL":"https:\/\/doi.org\/10.1111\/all.13076","archive":["Portico"],"relation":{},"ISSN":["0105-4538"],"issn-type":[{"value":"0105-4538","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}